South Australia Funded by Hospital Total hospital 3rd/4th n/a Website; – Australian (7 public and 6 utilisation DoHA; and ICU generation individual AUSP153, private coordinated usage rates cephalosporins, patient data 259 hospitals) by South for 6 glycopeptides, and Australian antimicrobial aggregated Infection classes statewide Control data; Service, and bimonthly reports; Disease penicillin with consumption Control beta-lactamase reported Branch inhibitor using combinations DDD/1000 occupied bed-days CHRISP Queensland HAI HSCID, Hospital Identification n/a n/a Website; (25 public surveillance Queensland and trends in individual hospitals) Health infection patient data AMR and and nosocomial aggregated pathogens statewide nosocomial data (to QLD Health) for facilities; provide data for national database
South Australian AUSP153, 259 Australia (7 public and 6 private hospitals) utilisation Funded by DoHA; coordinated by South Australian Infection Control Service, Disease Control Branch – Hospital Total hospital and ICU usage rates for 6 antimicrobial classes 3rd/4th generation cephalosporins, glycopeptides, and penicillin with beta-lactamase inhibitor combinations n/a Website; individual patient data and aggregated statewide data; bimonthly reports; consumption reported using DDD/1000 occupied bed-days CHRISP Queensland (25 public hospitals) HAI surveillance HSCID, Queensland Health Hospital Identification and trends in infection AMR and nosocomial pathogens n/a n/a Website; individual patient data and aggregated statewide nosocomial data (to QLD Health) for facilities; provide data for national database
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx